Mona Adel Mohamed

Mona Adel Mohamed

Auto-generated profile, based on publicly available information

Mona Adel Mohamed

Russell H. Morgan Department of Radiology and Radiological Sciences, Division of Neuroradiology, Johns Hopkins Hospital, Baltimore, MD, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2013 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
BFBradley R. Foerster
Bradley R. Foerster
MPMartin G. Pomper
Martin G. Pomper
BCBrian C. Callaghan
Brian C. Callaghan
MPMyria Petrou
Myria Petrou
RERichard A. E. Edden
Richard A. E. Edden
EFEva L. Feldman
Eva L. Feldman
Amyotrophic lateral sclerosis (ALS) is a progressive degenerative motor neuron disease involving the motor cortex, corticospinal tract, brainstem, and spinal anterior horn neurons.1 The disease is uniformly fatal, although the clinical presentation and course are heterogeneous, with median survival times between 2 and 4 years.2 Patients present most commonly with combined upper motor neuron (UMN) and lower motor neuron (LMN) features, although, earlier in the disease course, only UMN or LMN signs may be present. Although electromyography confirms LMN signs in ALS, UMN signs are solely assessed on clinical grounds that can delay diagnosis. This is due in part to the fact that UMN signs in ALS can be masked by LMN weakness and secondary hyporeflexia rather than hyperreflexia.3 Riluzole, the only medication for ALS approved by the US Food and Drug Administration, has limited efficacy, extending average life expectancy by only 3 to 6 months.4,5 Riluzole is postulated to modulate excitatory neurotransmission, although the exact in vivo pharmacologic actions are not well understood.6

16 March 2004 in Magnetic Resonance Materials in Physics, Biology and Medicine
Verified
Journal Article
Closed access
PDF file
IAI. M. Adame
I. M. Adame
RGR. J. van der Geest
R. J. van der Geest
BWB. A. Wasserman
B. A. Wasserman
MMM. A. Mohamed
M. A. Mohamed
JRJ. H. C. Reiber
J. H. C. Reiber
BLB. P. F. Lelieveldt
B. P. F. Lelieveldt

1 February 2009 in Sleep Medicine
Verified
Journal Article
Closed access
CEChristopher J. Earley
Christopher J. Earley
AHAlena Horská
Alena Horská
MMMona A. Mohamed
Mona A. Mohamed
PBPeter B. Barker
Peter B. Barker
JBJohn L. Beard
John L. Beard
RARichard P. Allen
Richard P. Allen

1 September 2013 in Academic Radiology
Verified
Journal Article
Closed access
BFBradley R. Foerster
Bradley R. Foerster
BDBen A. Dwamena
Ben A. Dwamena
MPMyria Petrou
Myria Petrou
RCRuth C. Carlos
Ruth C. Carlos
BCBrian C. Callaghan
Brian C. Callaghan
MPMartin G. Pomper
Martin G. Pomper

1 November 2010 in Magnetic Resonance Imaging
Verified
Journal Article
Closed access
MMMona A. Mohamed
Mona A. Mohamed
PBPeter B. Barker
Peter B. Barker
RSRichard L. Skolasky
Richard L. Skolasky
OSOla A. Selnes
Ola A. Selnes
RMRichard T. Moxley
Richard T. Moxley
NSNed C. Sacktor
Ned C. Sacktor

13 January 2014 in Annals of Clinical and Translational Neurology
Verified
Journal Article
Open access
PDF file
BFBradley R. Foerster
Bradley R. Foerster
RCRuth C. Carlos
Ruth C. Carlos
BDBen A. Dwamena
Ben A. Dwamena
BCBrian C. Callaghan
Brian C. Callaghan
MPMyria Petrou
Myria Petrou
MPMartin G. Pomper
Martin G. Pomper
Objective Reliable biomarkers for amyotrophic lateral sclerosis (ALS) are needed, given the clinical heterogeneity of the disease. Here, we provide proof‐of‐concept for using multimodal magnetic resonance imaging (MRI) as a diagnostic biomarker for ALS. Specifically, we evaluated the added diagnostic utility of proton magnetic resonance spectroscopy (MRS) to diffusion tensor imaging (DTI). Methods Twenty‐nine patients with ALS and 30 age‐ and gender‐matched healthy controls underwent brain MRI which used proton MRS including spectral editing techniques to measure γ‐aminobutyric acid (GABA) and DTI to measure fractional anisotropy of the corticospinal tract. Data were analyzed using logistic regression, t‐tests, and generalized linear models with leave‐one‐out analysis to generate and compare the resulting receiver operating characteristic (ROC) curves. Results The diagnostic accuracy is significantly improved when the MRS data were combined with the DTI data as compared to the DTI data only (area under the ROC curves (AUC) = 0.93 vs. AUC = 0.81; P = 0.05). The combined MRS and DTI data resulted in sensitivity of 0.93, specificity of 0.85, positive likelihood ratio of 6.20, and negative likelihood ratio of 0.08 whereas the DTI data only resulted in sensitivity of 0.86, specificity of 0.70, positive likelihood ratio of 2.87, and negative likelihood ratio of 0.20. Interpretation Combining multiple advanced neuroimaging modalities significantly improves disease discrimination between ALS patients and healthy controls. These results provide an important step toward advancing a multimodal MRI approach along the diagnostic test development pathway for ALS.